417 related articles for article (PubMed ID: 25479915)
1. Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice.
Gamage TF; Ignatowska-Jankowska BM; Muldoon PP; Cravatt BF; Damaj MI; Lichtman AH
Drug Alcohol Depend; 2015 Jan; 146():7-16. PubMed ID: 25479915
[TBL] [Abstract][Full Text] [Related]
2. Dual inhibition of endocannabinoid catabolic enzymes produces enhanced antiwithdrawal effects in morphine-dependent mice.
Ramesh D; Gamage TF; Vanuytsel T; Owens RA; Abdullah RA; Niphakis MJ; Shea-Donohue T; Cravatt BF; Lichtman AH
Neuropsychopharmacology; 2013 May; 38(6):1039-49. PubMed ID: 23303065
[TBL] [Abstract][Full Text] [Related]
3. Blockade of endocannabinoid hydrolytic enzymes attenuates precipitated opioid withdrawal symptoms in mice.
Ramesh D; Ross GR; Schlosburg JE; Owens RA; Abdullah RA; Kinsey SG; Long JZ; Nomura DK; Sim-Selley LJ; Cravatt BF; Akbarali HI; Lichtman AH
J Pharmacol Exp Ther; 2011 Oct; 339(1):173-85. PubMed ID: 21719468
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of endocannabinoid-metabolizing enzymes reduce precipitated withdrawal responses in THC-dependent mice.
Schlosburg JE; Carlson BL; Ramesh D; Abdullah RA; Long JZ; Cravatt BF; Lichtman AH
AAPS J; 2009 Jun; 11(2):342-52. PubMed ID: 19430909
[TBL] [Abstract][Full Text] [Related]
6. Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice.
Wiebelhaus JM; Grim TW; Owens RA; Lazenka MF; Sim-Selley LJ; Abdullah RA; Niphakis MJ; Vann RE; Cravatt BF; Wiley JL; Negus SS; Lichtman AH
J Pharmacol Exp Ther; 2015 Feb; 352(2):195-207. PubMed ID: 25398241
[TBL] [Abstract][Full Text] [Related]
7. Discriminative Stimulus Properties of the Endocannabinoid Catabolic Enzyme Inhibitor SA-57 in Mice.
Owens RA; Ignatowska-Jankowska B; Mustafa M; Beardsley PM; Wiley JL; Jali A; Selley DE; Niphakis MJ; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2016 Aug; 358(2):306-14. PubMed ID: 27307500
[TBL] [Abstract][Full Text] [Related]
8. Reducing endocannabinoid metabolism with the fatty acid amide hydrolase inhibitor, URB597, fails to modify reinstatement of morphine-induced conditioned floor preference and naloxone-precipitated morphine withdrawal-induced conditioned floor avoidance.
McCallum AL; Limebeer CL; Parker LA
Pharmacol Biochem Behav; 2010 Oct; 96(4):496-500. PubMed ID: 20643159
[TBL] [Abstract][Full Text] [Related]
9. Systemic and spinal administration of FAAH, MAGL inhibitors and dual FAAH/MAGL inhibitors produce antipruritic effect in mice.
Yesilyurt O; Cayirli M; Sakin YS; Seyrek M; Akar A; Dogrul A
Arch Dermatol Res; 2016 Jul; 308(5):335-45. PubMed ID: 27126057
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
Walentiny DM; Vann RE; Wiley JL
Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous inhibition of fatty acid amide hydrolase and monoacylglycerol lipase shares discriminative stimulus effects with Δ9-tetrahydrocannabinol in mice.
Hruba L; Seillier A; Zaki A; Cravatt BF; Lichtman AH; Giuffrida A; McMahon LR
J Pharmacol Exp Ther; 2015 May; 353(2):261-8. PubMed ID: 25711338
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.
Kinsey SG; O'Neal ST; Long JZ; Cravatt BF; Lichtman AH
Pharmacol Biochem Behav; 2011 Mar; 98(1):21-7. PubMed ID: 21145341
[TBL] [Abstract][Full Text] [Related]
13. The effects of fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on lipopolysaccharide-induced airway inflammation in mice.
Abohalaka R; Bozkurt TE; Nemutlu E; Onder SC; Sahin-Erdemli I
Pulm Pharmacol Ther; 2020 Jun; 62():101920. PubMed ID: 32416152
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
Spradley JM; Guindon J; Hohmann AG
Pharmacol Res; 2010 Sep; 62(3):249-58. PubMed ID: 20416378
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoid Catabolic Enzymes Play Differential Roles in Thermal Homeostasis in Response to Environmental or Immune Challenge.
Nass SR; Long JZ; Schlosburg JE; Cravatt BF; Lichtman AH; Kinsey SG
J Neuroimmune Pharmacol; 2015 Jun; 10(2):364-70. PubMed ID: 25715681
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of monoacylglycerol lipase reduces nicotine withdrawal.
Muldoon PP; Chen J; Harenza JL; Abdullah RA; Sim-Selley LJ; Cravatt BF; Miles MF; Chen X; Lichtman AH; Damaj MI
Br J Pharmacol; 2015 Feb; 172(3):869-82. PubMed ID: 25258021
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors.
Bedse G; Bluett RJ; Patrick TA; Romness NK; Gaulden AD; Kingsley PJ; Plath N; Marnett LJ; Patel S
Transl Psychiatry; 2018 Apr; 8(1):92. PubMed ID: 29695817
[TBL] [Abstract][Full Text] [Related]
18. The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents.
Sakin YS; Dogrul A; Ilkaya F; Seyrek M; Ulas UH; Gulsen M; Bagci S
Neurogastroenterol Motil; 2015 Jul; 27(7):936-44. PubMed ID: 25869205
[TBL] [Abstract][Full Text] [Related]
19. Behavioral Battery for Testing Candidate Analgesics in Mice. II. Effects of Endocannabinoid Catabolic Enzyme Inhibitors and ∆9-Tetrahydrocannabinol.
Diester CM; Lichtman AH; Negus SS
J Pharmacol Exp Ther; 2021 May; 377(2):242-253. PubMed ID: 33622769
[TBL] [Abstract][Full Text] [Related]
20. The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice.
Wilkerson JL; Ghosh S; Mustafa M; Abdullah RA; Niphakis MJ; Cabrera R; Maldonado RL; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Mar; 114():156-167. PubMed ID: 27890602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
